1-10 of 10
Erik P. Sulman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma

Sylvia C. Kurz, Elcin Zan, Christine Cordova, Andrea B. Troxel, Marissa Barbaro, Joshua S. Silverman, Matija Snuderl, David Zagzag, Douglas Kondziolka, John G. Golfinos, Andrew S. Chi, Erik P. Sulman
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (4): 680–686.
https://doi.org/10.1158/1078-0432.CCR-23-2533
Published: 16 February 2024
View article titled, Evaluation of the SSTR2-targeted Radiopharmaceutical <sup>177</sup>Lu-DOTATATE and SSTR2-specific <sup>68</sup>Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma
Open the PDF for Evaluation of the SSTR2-targeted Radiopharmaceutical <sup>177</sup>Lu-DOTATATE and SSTR2-specific <sup>68</sup>Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma in another window
Includes: Supplementary data
Journal Articles

Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

Stephen J. Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Louis Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 594–602.
https://doi.org/10.1158/1078-0432.CCR-21-2750
Published: 15 February 2022
View article titled, Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Open the PDF for Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement in another window
Journal Articles

Abstract PO-019: Radiotherapy in cancer is associated with a deletion signature that contributes to poor patient outcomes

Emre Kocakavuk, Kevin J. Anderson, Frederick S. Varn, Kevin C. Johnson, Samirkumar B. Amin, Erik. P. Sulman, Martijn Lolkema, Floris P. Barthel, Roel G.W. Verhaak
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-019.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-019
Published: 15 April 2021
View article titled, Abstract PO-019: Radiotherapy in cancer is associated with a deletion signature that contributes to poor patient outcomes
Journal Articles

Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy

Martina Ott, Cynthia Kassab, Anantha Marisetty, Yuuri Hashimoto, Jun Wei, Daniel Zamler, Jia-Shiun Leu, Karl-Heinz Tomaszowski, Aria Sabbagh, Dexing Fang, Pravesh Gupta, Waldemar Priebe, Rafal J. Zielinski, Jared K. Burks, James P. Long, Ling-Yuan Kong, Gregory N. Fuller, John DeGroot, Erik P. Sulman, Amy B. Heimberger
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (18): 4983–4994.
https://doi.org/10.1158/1078-0432.CCR-19-4092
Published: 15 September 2020
View article titled, Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy
Open the PDF for Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy in another window
Includes: Multimedia, Supplementary data
Journal Articles

EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma

Shaofang Wu, Feng Gao, Siyuan Zheng, Chen Zhang, Emmanuel Martinez-Ledesma, Ravesanker Ezhilarasan, Jie Ding, Xiaolong Li, Ningping Feng, Asha Multani, Erik P. Sulman, Roel G. Verhaak, John F. de Groot, Tim P. Heffernan, W.K. Alfred Yung, Dimpy Koul
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1395–1407.
https://doi.org/10.1158/1078-0432.CCR-19-2549
Published: 13 March 2020
View article titled, <em>EGFR</em> Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma
Open the PDF for <em>EGFR</em> Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

Rachael A. Vaubel, Shulan Tian, Dioval Remonde, Mark A. Schroeder, Ann C. Mladek, Gaspar J. Kitange, Alissa Caron, Thomas M. Kollmeyer, Rebecca Grove, Sen Peng, Brett L. Carlson, Daniel J. Ma, Gobinda Sarkar, Lisa Evers, Paul A. Decker, Huihuang Yan, Harshil D. Dhruv, Michael E. Berens, Qianghu Wang, Bianca M. Marin, Eric W. Klee, Andrea Califano, Daniel H. LaChance, Jeanette E. Eckel-Passow, Roel G. Verhaak, Erik P. Sulman, Terry C. Burns, Fredrick B. Meyer, Brian P. O'Neill, Nhan L. Tran, Caterina Giannini, Robert B. Jenkins, Ian F. Parney, Jann N. Sarkaria
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 1094–1104.
https://doi.org/10.1158/1078-0432.CCR-19-0909
Published: 02 March 2020
View article titled, Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
Open the PDF for Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

Marissa Spino, Sylvia C. Kurz, Luis Chiriboga, Jonathan Serrano, Briana Zeck, Namita Sen, Seema Patel, Guomiao Shen, Varshini Vasudevaraja, Aristotelis Tsirigos, Carter M. Suryadevara, Joshua D. Frenster, Kensuke Tateishi, Hiroaki Wakimoto, Rajan Jain, Howard A. Riina, Theodore P. Nicolaides, Erik P. Sulman, Daniel P. Cahill, John G. Golfinos, Kumiko Isse, Laura R. Saunders, David Zagzag, Dimitris G. Placantonakis, Matija Snuderl, Andrew S. Chi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (4): 1261–1271.
https://doi.org/10.1158/1078-0432.CCR-18-2312
Published: 15 February 2019
View article titled, Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma
Open the PDF for Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma in another window
Includes: Supplementary data
Journal Articles

A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models

Pascal O. Zinn, Sanjay K. Singh, Aikaterini Kotrotsou, Islam Hassan, Ginu Thomas, Markus M. Luedi, Ahmed Elakkad, Nabil Elshafeey, Tagwa Idris, Jennifer Mosley, Joy Gumin, Gregory N. Fuller, John F. de Groot, Veera Baladandayuthapani, Erik P. Sulman, Ashok J. Kumar, Raymond Sawaya, Frederick F. Lang, David Piwnica-Worms, Rivka R. Colen
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (24): 6288–6299.
https://doi.org/10.1158/1078-0432.CCR-17-3420
Published: 13 December 2018
View article titled, A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models
Open the PDF for A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models in another window
Includes: Supplementary data
Journal Articles

Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas

Alessandro Canella, Alessandra M. Welker, Ji Young Yoo, Jihong Xu, Fazly S. Abas, Divya Kesanakurti, Prabakaran Nagarajan, Christine E. Beattie, Erik P. Sulman, Joseph Liu, Joy Gumin, Frederick F. Lang, Metin N. Gurcan, Balveen Kaur, Deepa Sampath, Vinay K. Puduvalli
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6215–6226.
https://doi.org/10.1158/1078-0432.CCR-16-3151
Published: 12 October 2017
View article titled, Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas
Open the PDF for Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas in another window
Includes: Supplementary data
Journal Articles

Genetic Modulation of Neurocognitive Function in Glioma Patients

Yanhong Liu, Renke Zhou, Erik P. Sulman, Michael E. Scheurer, Nicholas Boehling, Georgina N. Armstrong, Spiridon Tsavachidis, Fu-Wen Liang, Carol J. Etzel, Charles A. Conrad, Mark R. Gilbert, Terri S. Armstrong, Melissa L. Bondy, Jeffrey S. Wefel
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3340–3346.
https://doi.org/10.1158/1078-0432.CCR-15-0168
Published: 14 July 2015
View article titled, Genetic Modulation of Neurocognitive Function in Glioma Patients
Open the PDF for Genetic Modulation of Neurocognitive Function in Glioma Patients in another window
Includes: Supplementary data